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Abstract: Maternal nutrition in pregnancy has a key influence on optimum fetal health. Eating
disorders (EDs) during pregnancy may have detrimental effects on fetal growth and the child’s
early development. There is limited knowledge concerning the eating behavior, dietary intake and
derived nutritional biomarkers as well as the nutrient supplementation in women with EDs during
pregnancy. We performed a systematic review according to the PRISMA statement to synthesize
current evidence in this field. Of N = 1203 hits, 13 full-texts were included in the qualitative synthesis.
While women with current Binge Eating Disorder (BED) showed higher energy and fat intakes during
pregnancy, women with a lifetime Anorexia Nervosa (AN), Bulimia Nervosa (BN) or both (AN + BN)
had similar patterns of nutrient intake and dietary supplement use as healthy women. There is
evidence, that women with a history of EDs have a sufficient diet quality and are more likely to be
vegetarian. Dieting and bingeing improved substantially with pregnancy. The highlighted differences
in the consumption of coffee/caffeine and artificially sweetened beverages as well as the elevated
prevalence of iron deficiency anemia in women with a past or active ED during pregnancy might
have an important impact on fetal development.
Keywords: anorexia nervosa; bulimia nervosa; binge eating disorder; diet; eating behavior; eating
disorders; nutrition; pregnancy; purging
1. Introduction
In pregnancy, a lifestyle characterized by regular exercise and a balanced and diverse diet is
a significant determinant of the course of pregnancy, the child’s development, and the short- and
long-term health of the mother and child [1]. In relation to the slight increase in energy intake in the last
months of pregnancy, the demand for some vitamins and minerals (including trace elements) increases
significantly more [1], usually from the 4th month of pregnancy on [2]. For the nutrients folate and
iodine, a markedly increased intake is recommended from the beginning of pregnancy or, ideally, before
conception [2]. There is substantial interest in nutrition during pregnancy, due to the extensive research
in the area of early nutrition programming [3], arisen from the initial work by Barker (‘Fetal Origins of
Adult Disease’; FOAD) [4]. Barker’s initial concept was later modified to the ‘Developmental Origins of
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Health and Disease’ (DOHaD) [5], which postulates that exposure to certain environmental influences
during critical periods of development (e.g., intrauterine deficiency or oversupply of nutrients) and
growth may have a significant impact on the development of non-communicable diseases (NCDs), such
as obesity, diabetes mellitus, cardiovascular and mental disorders, as well as cancer in later life [5–7].
Given that eating disorders (EDs) are characterized by dysfunctional eating behaviors (e.g.,
caloric restriction, purging behavior), which may result in specific maternal macro- and micronutrient
deficiencies, one would predict negative consequences of maternal EDs on the health, growth, and
development of the fetus and the newborn infant. Research suggests that up to 7.5% of pregnant women
are affected by an ED [8]. EDs include Anorexia Nervosa (AN), Bulimia Nervosa (BN), Binge Eating
Disorder (BED) and ‘Other Specified Feeding or Eating Disorders’ (OSFED) [9]. AN is characterized
by an excessive restriction of energy intake, which leads to severe weight loss with a pathological
fear of weight gain and a distorted body image [9]. BN is defined by regular episodes of binge eating
followed by inappropriate compensatory behaviors such as self-induced vomiting, abuse of laxatives,
fasting or excessive exercise to avoid weight gain [9]. BED is associated with recurring episodes of
eating significantly more food in a short period of time than most people would eat under comparable
conditions, accompanied by feelings of lack of control, guilt, embarrassment or disgust [9].
There is increasing evidence from large cohort studies and register data showing that maternal
disordered eating behavior and dysregulated body weight have detrimental effects on the course of
pregnancy and birth outcomes. Pregnant women with an active ED are at increased risk of experiencing
antepartum hemorrhage [10], hyperemesis gravidarum [11], higher rates of miscarriage [12], caesarean
sections, and postpartum depression [13]. The literature on fetal outcomes of women with EDs
displays lower [14] and higher birth weights [15,16], intrauterine growth restriction [10], small head
circumferences [17], neurobehavioral dysregulations early after birth [18] as well as premature deliveries
and perinatal mortality [15]. Disturbances and dysfunctions related to nutrition and eating behaviors
which are core symptoms of EDs might contribute to these adverse pregnancy outcomes seen in women
with EDs. On the other hand, given that affected women are often unduly preoccupied by eating
and weight-control practices, they might have a higher nutritional knowledge, especially in terms of
nutrient sources [19]. Therefore, one could also assume that at least subgroups of women with EDs
might have a higher diet quality during pregnancy. Although most studies report an improvement in
the ED symptomatology during pregnancy [20–23], there is limited knowledge about the actual food
intake and overall dietary behavior of pregnant women with EDs.
The present systematic review aims to provide a synthesis of evidence regarding overall nutrition
and related issues of pregnant women with a history of EDs. The main research questions are:
1. Do pregnant women with a history of EDs show different dietary intakes and patterns as compared
to healthy pregnant women?
2. Do pregnant women with a history of EDs deviate from international dietary recommendations
guidelines for pregnancy?
3. Do pregnant women with a history of EDs differ from healthy pregnant women with regard to
nutritional biomarkers and dietary supplement intake?
4. Do pregnant women with a history of EDs show dysfunctional eating behaviors, i.e., restrictive
eating, dieting, binge eating? Here, we will focus exclusively on behavioral eating aspects (which
also represent ED symptoms), but not solely on ED symptoms with no direct connection to food
intake (e.g., self-induced vomiting).
2. Methods
The review process was conducted according to the ‘Preferred Reporting Items for Systematic
Reviews and Meta-Analyses’ (PRISMA) [24]. Papers were searched on PubMed and PsycInfo and
covered a period ranging from 1987 to November 2018. The approach of this systematic review was
specified in advance and documented in a protocol.
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2.1. Search Strategy
Studies were identified by searching electronic databases and scanning reference lists of articles
for relevant studies. The search was applied using the scientific databases PubMed and PsycInfo.
In addition, we handsearched contents pages of ‘The International Journal of Eating Disorders’, the
‘Journal of Eating Disorders’, the ‘European Eating Disorders Review’, ‘Eating Disorders: The Journal
of Treatment and Prevention’ and ‘Nutrients’.
Until November 2018, a search of two databases was performed using the terms ‘nutrition’, ‘food
intake’, ‘eating behavior’, ‘pregnancy’, and ‘eating disorders’. As an example, for the PubMed search,
the search term was defined as follows:
‘((((“nutritional status”[MeSH Terms] OR (“nutritional”[All Fields] AND “status”[All Fields])
OR “nutritional status”[All Fields] OR “nutrition”[All Fields] OR “nutritional sciences”[MeSH Terms]
OR (“nutritional”[All Fields] AND “sciences”[All Fields]) OR “nutritional sciences”[All Fields]) OR
(“eating”[MeSH Terms] OR “eating”[All Fields] OR (“food”[All Fields] AND “intake”[All Fields])
OR “food intake”[All Fields])) OR (“eating behaviour”[All Fields] OR “feeding behavior”[MeSH
Terms] OR (“feeding”[All Fields] AND “behavior”[All Fields]) OR “feeding behavior”[All Fields]
OR (“eating”[All Fields] AND “behavior”[All Fields]) OR “eating behavior”[All Fields])) AND
(“pregnancy”[MeSH Terms] OR “pregnancy”[All Fields])) AND (“feeding and eating disorders”[MeSH
Terms] OR (“feeding”[All Fields] AND “eating”[All Fields] AND “disorders”[All Fields]) OR “feeding
and eating disorders”[All Fields] OR (“eating”[All Fields] AND “disorders”[All Fields]) OR “eating
disorders”[All Fields]) AND “humans”[MeSH Terms]’.
The first stage of study selection included the removal of duplicate studies, conducted by the
paper’s first author (A.F.D.). The first and the fourth author (S.B.L.) roughly screened the remaining
studies by scanning article titles and abstracts. In the next step, the same two authors performed full text
examinations of potentially relevant studies according to the defined eligibility criteria. Disagreements
were resolved by discussion between the two investigators; if no agreement could be reached, the last
review author (K.E.G.) was consulted.
The first author then extracted information from each included study using a specifically designed
data collection sheet. The data collection sheet sought the following variables: (i) study characteristics
(including study design, follow-up period, study size, country, funding sources), and the trial’s
inclusion and exclusion criteria; (ii) characteristics of trial participants (including method of ED
diagnosis, gestational week); (iii) type of outcome measures (including dietary quantity and quality,
eating patterns, dietary supplement use, nutritional biomarkers, and eating behavior in general), and
results (including limitations, strengths, clinical implications and conclusions).
2.2. Eligibility Criteria
Eligibility criteria were based on the five PICOS dimensions, i.e., participants (P), interventions (I),
comparators (C), outcome (O) and study design (S) [25].
2.2.1. Participants
Participants included pregnant women of any age with a past or current ED. Eating disorders were
defined as AN, BN, BED and OSFED, previously known as ‘Eating Disorder Not Otherwise Specified’
(EDNOS), according to DSM criteria. Pica, an eating disorder that involves the persistent eating of
substances that are not food and do not provide nutritional value, was defined as exclusion criterion
for this review, as Pica is often described inaccurately as a part of culturally supported or socially
normative practices [26]. Pregnant women with additional severe mental disorders (e.g., dementia,
schizophrenia) as well as somatic syndromes influencing weight or eating behavior (e.g., diabetes
mellitus, epilepsy, Prader-Willi syndrome), or virus infections (e.g., malaria) were excluded from
this review.
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2.2.2. Interventions
Trials assessing the dietary intake and eating patterns of pregnant women with a history of EDs
in comparison to pregnant women without EDs. Dietary intake includes dietary quality, dietary
supplement use, and eating behavior in general. Additionally, this review includes studies reporting
on nutritional biomarkers of under- or malnutrition.
2.2.3. Comparators
Studies were eligible if a control group was included that consisted of pregnant women without
any EDs. If there was no control group assessed, international dietary recommendation guidelines for
pregnancy were used as a comparator [1,27,28].
2.2.4. Outcome
Primary outcome measures: Dietary intake in terms of food quantity and food quality, eating
patterns regarding different forms of nutrition (e.g., vegetarianism, veganism), dietary supplement
use (e.g., vitamin supplements), and nutritional biomarkers (e.g., ferritin). Secondary outcome measures:
eating behavior in general (e.g., dieting or binge eating).
2.2.5. Study design
Cross-sectional and longitudinal observational studies assessing the dietary intake and eating
patterns of pregnant women with a history of EDs. No publication date restrictions were imposed.
Unpublished material and abstracts were included; publications in form of book chapters, reviews, case
reports/series or dissertations were excluded. This review was limited to studies in English, French or
German language.
3. Results
A total of 13 studies were identified for inclusion in this review. Interrater reliability was good,
with κ = 0.71. See the flow diagram for an overview of the study selection process (Figure 1).
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We clustered the 13 studies according to the following topics concerning pregnant women
with EDs:
1. Dietary intake/quality and patterns (n = 3)
2. Nutritional biomarkers and dietary supplement use (n = 3)
3. Eating behavior (n = 7)
3.1. Studies Investigating Dietary Intake and Patterns in Pregnant Women with Eating Disorders
We identified three studies which investigated dietary intakes in pregnancy in women with lifetime
EDs [29–31]. All three studies were cross-sectional analyses, using data from large population-based
cohort studies (see Table 1). Women with lifetime EDs were compared with control women free of any
EDs before or during pregnancy. Maternal history of lifetime EDs was assessed during pregnancy [31]
with self-reported questionnaires, either at gestational week (GW) 12 [29], or at six months prior to
pregnancy and at GW 18.1 [30]. Dietary information was collected via food frequency questionnaires
(FFQs) in the first half of the pregnancy [30,31] and in the third trimester [29]. The FFQ determines the
frequency of consumption and the portion size of a wide variety of foods and drinks. Additionally,
Micali et al. [29] and Siega-Riz et al. [30] combined related foods into different food groups (e.g., red
meat, poultry, sausages/burgers, pies/pasties = ‘meat’). Two of the three studies [29,30] examined the
exact dietary intake of pregnant women across the ED spectrum in comparison to pregnant women
without EDs. Siega-Riz et al. [30] focused on nutrient and food group intakes of pregnant women with
BED and BN in the second trimester. Micali et al. [29] examined the dietary intake as well as dietary
patterns of pregnant women with AN, BN or both (AN + BN) in the third trimester.
In terms of macronutrient intake, there were no differences to healthy pregnant women in
energy, carbohydrate, fat and protein consumption of pregnant women with AN, BN or both in the
third trimester [29]. In contrast, women with BED before and during pregnancy showed a higher
consumption of total energy and total fat (monounsaturated fatty acids, MUFA; saturated fatty acids,
SFA) in the second trimester [30]. Women who developed BED during pregnancy also had a higher
total energy and SFA intake [30].
With regard to micronutrient intake through diet, there was very little difference in pregnancy in
women with EDs compared with control women [29,30]. In particular, women in the second trimester
with BED before and during pregnancy had lower intakes of folate, potassium and vitamin C [30].
This is reflected in the food group consumption, showing lower intakes of fruit and juices in those
women [30]. In the third trimester, women with AN and AN + BN had higher folate and potassium
intakes; women with AN + BN showed higher intakes of calcium, phosphorus, zinc, and vitamin C and
women with BN had a slightly higher vitamin E intake compared to control women [29]. In general, the
average mineral and vitamin intakes were satisfying in women with EDs throughout pregnancy [27,28].
In relation to food group consumption, women with BED before and during pregnancy had
higher intakes of overall fat (butter, margarines, and oils) and milk desserts in the second trimester [30].
Pregnant women with AN, BN or both in the third trimester were less likely to use butter and drink
full-fat milk in favor of skimmed and soya milk [29]. Those women also consumed less meat and fewer
potatoes; however, they had a higher intake of soya products and pulses compared to the referent
group [29]. Similarly, women with BN before and during pregnancy had a lower intake of high-fat
meats in the second trimester [30]. Moreover, a higher consumption of artificially sweetened beverages
among women with active and past BN and BED was observed [30]. Women with an active BED
showed a slight increase in mean coffee consumption and women with lifetime AN and AN + BN
reported a significantly higher coffee consumption (>355 mg caffeine/week) during pregnancy [29,30].
Regarding dietary patterns, women with lifetime EDs scored higher on the vegetarian dietary
pattern (high intakes of meat substitutes, pulses, nuts and herbal teas, and high negative intakes of
red meat and poultry), which corresponds to their self-report as being vegetarian [29]. Women with a
lifetime AN scored higher on the ‘traditional’ dietary pattern (high loadings for all types of vegetables
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and red meat and poultry); women with a lifetime AN + BN scored higher on the ‘health conscious’
(high intake of salad, fruit, rice, pasta, oat and bran-based breakfast cereals, fish, pulses, fruit juices
and non-white bread) and the ‘traditional’ dietary pattern [29].
Nguyen et al. [31] calculated a diet quality score with the data of the FFQs on the basis of the
Dutch national dietary guidelines, including 15 components and cut-offs (e.g., vegetables (≥200 g/day),
dairy (≥300 g/day), and red meat (≤375 g/week)). After adjustment for socioeconomic and lifestyle
factors (maternal age, ethnicity, educational level, BMI, household income, psychiatric symptoms),
women with a history of EDs had a significantly higher diet quality score than women unexposed [31].
3.2. Studies Investigating Maternal Biomarkers of Nutrition and Dietary Supplement Use in Pregnant Women
with Eating Disorders
We identified two studies which assessed maternal biomarkers of nutrition in pregnant women
with a history of EDs [15,32], and one study which focused on the dietary supplement use in those
women [33] (see Table 2).
Koubaa et al. [32] examined biomarkers of nutrition and stress during early pregnancy in a cohort
of women with a previous history of AN or BN in comparison to healthy women. Women with a
history of AN showed a significantly higher frequency of anemia (hemoglobin, Hb < 110 g/L), which
was related to low levels of maternal serum ferritin in early pregnancy compared to controls (p < 0.01).
In their large register search study (n = 4299), Linna et al. [15] also found an increased occurrence of
anemia in women with AN compared to healthy controls.
Regarding dietary supplement use, Dellava et al. [33] performed a cross-sectional analysis of the
Norwegian Mother and Child Cohort Study (MoBa). Over 90% of women with an ED diagnosis as well
as women without EDs used dietary supplements during pregnancy. Folic acid supplementation was
the most common dietary supplement. After adjusting for covariates (maternal age, parity, smoking,
household income, and educational level), no significant differences existed across groups for the use
of any dietary supplement during pregnancy. However, women with EDNOS-P (purging subtype)
were significantly more likely to take iron supplements during pregnancy (p < 0.04) [33].
3.3. Studies Investigating Eating Behavior in Pregnant Women with EDs
Concerning dysfunctional eating behaviors in pregnant women with a history of EDs, we identified
seven relevant studies [20,23,34–38]. These studies provide evidence for a general improvement in
dysfunctional eating behaviors during pregnancy in women with a recent or past ED (see Table 3).
Women who actively suffered from BN during pregnancy reported an improvement of objective binge
episodes with each passing trimester [36,37]. In particular, the frequency of objective binge eating in
pregnant women with full or partial AN, BN or BED decreased to 2.9 episodes per 28 days intrapartum
compared to 8.7 episodes prepartum [23]. 65% of pregnant women with an active BN, AN or mixed
symptoms (AN + BN) who restricted their intake reported that they improved nutritionally or stopped
restricting entirely; 56% of those who binged improved during pregnancy [38]. Blais et al. [20] also
found a decrease in binge frequency in women with an active BN intrapartum, but no significant
differences for binge frequencies and restrictive eating were seen in women with an active AN. For
pregnant women with an active AN, BN or both, there was also evidence that bingeing became worse
in pregnancy (18%) and that increased impulsivity within food intake resulted in overeating in 12% of
those women [38]. Cross-sectional analyses of the Avon Longitudinal Study of Parents and Children
(ALSPAC) revealed that 11.3% of women with a recent ED and 4.4% of women with a past ED dieted
in late pregnancy, compared to 8% of obese and 2.5% of nonobese control women [34]. Regarding the
question of whether they felt a loss of control over eating (LOC) during pregnancy, 72.5% of women
with a recent ED and 42.8% of women with a past ED as well as 33.8% of healthy obese women and
36.1% of healthy nonobese women confirmed this question. Especially women with a recent BN were
more likely to report LOC in pregnancy compared to all other groups [34].
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Table 1. Studies investigating dietary intake/quality/patterns in pregnant women with eating disorders.
Source Study Design Country Sample ED Diagnosis n Prevalence of EDs Outcome Dietary Information
Nguyen et al., 2017
[31]
Cross-sectional
analysis of the
Generation R
study
Netherlands Pregnant women with andwithout a history of any ED
Self-reported questionnaire
and clinical diagnoses
(subsample; n = 928) during
pregnancy
6196 9.5%(n = 591)
Diet quality score,
including 15
components and
cut-offs (e.g., vegetables
(≥200 g/day), dairy
(≥300 g/day), red meat
(≤375 g/week))
Semi-quantitative
modified 293-item FFQ at
13.6 weeks of gestation
(12.4–16.2)
Main findings Women with a history of EDs had a higher diet quality score than women without EDs
Micali et al., 2012
[29]
Cross-sectional
analysis of the
ALSPAC study
United
Kingdom
Pregnant women with and
without a lifetime AN, BN, and
AN + BN (exclusion:
non-singleton pregnancies,
miscarriage)
Self-reported questionnaire
at 12 weeks of gestation 10,137
4.1% (n = 414);
AN (n = 151);
BN (n = 186);
AN + BN (n = 77)
Frequency of
consumption of various
food groups, daily
nutrient intakes
(macronutrients), and
dietary patterns
FFQ at 32 weeks of
gestation; 14 food groups,
5 dietary patterns
Main findings
(compared to
control women)
1. Women with lifetime ED:
- 2.8 times more likely to describe themselves as vegetarian
- ↑ scoring on ‘vegetarian’ dietary pattern
- ↓meat, potatoes, SFA (AN, AN + BN)
- ↑ soya products, pulses, skimmed and soya milk, fiber
- ↓ butter, full-fat milk
- ↑ caffeine (>355 mg/day) (esp. AN, AN + BN)
2. Women with a lifetime AN:
- ↑ scoring on ‘traditional’ dietary pattern
3. Women with a lifetime BN:
- ↑ bread (1.1 slices/d more), PUFA
- ↓ sugar, non-milk extrinsic sugar
4. Women with a lifetime AN + BN:
- ↑ scoring on ‘health conscious’ and ‘traditional’ dietary pattern
Siega-Riz et al., 2008
[30]
Cross-sectional
analysis of the
MoBA study
Norway Pregnant women with andwithout lifetime BN and BED
Self-reported questionnaire 6
month before and during
pregnancy (18.1 week of
gestation)
30,040
6.1% lifetime ED (n = 1840); 4.6%
active ED (n = 1393); BN/BN (n = 59);
BN/BED (n = 60); BED/BED (n = 650);
none/BED (n = 624)
Nutrient and food
group intakes
Semi-quantitative FFQ at
gestational weeks 15–22;
255 questions, 20 food
groups
Main findings
(compared to
control women)
1. Women with BED before + during pregnancy:
- ↑ total energy (2459.0 ± 30.2 kcal vs. 2348.3 ± 4.6 kcal)
- ↑ total fat (87.5 ± 1.2 g vs. 80.8 ± 0.2 g)
- ↑MUFA (27.8 ± 0.4 g vs. 26.6 ± 0.1 g)
- ↑ SFA (34.2 ± 0.5 g vs. 31.3 ± 0.1 g)
- ↓ folate (268.9 ± 3.8 µg vs. 273.4 ± 0.7 µg)
- ↓ potassium (4008.1 ± 49 mg vs. 4018.6 ± 7.6 mg)
- ↓ vitamin C (155.5 ± 3.7 mg vs. 167.5 ± 0.6 mg)
- ↑ butter, margarines, oils, milk desserts, candy, coffee
- ↓ fruit, juices, chicken
2. Women with incident BED during pregnancy:
- ↑ total energy (2544.1 ± 41.2 kcal vs. 2348.3 ± 4.6 kcal)
- ↑ SFA (34.9 ± 0.6 g vs. 31.3 ± 0.1 g)
- ↑ cakes, candy, milk desserts, coffee; ↓ juices
3. Women with BN before and during pregnancy:
- ↑ yogurt, cheeses
- ↓ sweetened beverages, high-fat meats
Abbreviations: ED: eating disorder; AN: Anorexia Nervosa; BN: Bulimia Nervosa; BED: Binge Eating Disorder; ALSPAC: Avon Longitudinal Study of Parents and Children: MoBa:
Norwegian Mother and Child Cohort Study; FFQ: Food Frequency Questionnaire; ↑: higher (consumption); ↓: lower (consumption); SFA: saturated fatty acids; MUFA: monounsaturated
fatty acids; PUFA: polyunsaturated fatty acids; BN/BN = BN before and during pregnancy; BN/BED = BN before, BED during pregnancy; BED/BED = BED before and during pregnancy;
none/BED = no ED before, BED during pregnancy.
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Table 2. Studies investigating nutritional biomarkers and dietary supplement use in pregnant women with eating disorders.
Source Study Design Country Sample ED Diagnosis n Prevalence of EDs Outcome Main Findings
Koubaa et al.,
2015
[32]
Longitudinal
cohort study
(follow-up
period: 1 year)
Sweden
Pregnant,
nulliparous
non-smoking
women with and
without a history of
AN and BN
Interview according
to DSM-IV
diagnostic criteria;
medical records
96
38.5% (n = 37);
AN (active AN: n =
8; past AN: n = 12);
BN (active BN: n =
1; past BN: n = 16)
Maternal serum biomarkers of
nutrition and stress at 10 weeks of
gestation within a routine blood
sample (ferritin, cortisol, TSH, T4,
insulin, IGF-I and IGFBP1)
Women with previous AN:
- ↑ frequency (70%) of anemia (Hb <
110 g/L) compared to controls (12%)
1. ↓ serum ferritin levels compared
to controls
Linna et al., 2014
[15]
Register search
study Finland
Female ED patients
and unexposed
controls
Attending
physicians at the
clinic with ICD-10
(AN, BN, atypical
AN/BN) and
DSM-IV (BED)
criteria
4299
15.3% (n = 657);
AN (n = 182);
BN (n = 436);
BED (n = 39)
Pregnancy complications (obtained
from Medical Birth Register):
gestational diabetes mellitus, initiation
of insulin treatment, anemia, antenatal
corticosteroid treatment,
pregnancy-related ICD-10 diagnoses
Anemia was more frequent among women
with AN (3.97%) compared with unexposed
women (1.54%)
Dellava et al.,
2013
[33]
Cross-sectional
analysis of the
MoBA study
Norway
Pregnant women
across eating
disorder subtypes
compared with a
referent group
Self-reported
questionnaire at
GW 19
37,307
6.3% (n = 2348);
AN (n = 34);
BN (n = 326);
BED (n = 1944);
EDNOS-P (n = 44)
Use of dietary supplements (checklist
including 22 specific nutrients, at three
time points prior to pregnancy (≥9
weeks, 8–5 weeks and 4–1 week before
conception) and eight time periods
during pregnancy (GW 1–4, 5–8, 9–12
13–16, 17–20, 21–24, 25–28, and 29+)
Dietary supplement use during pregnancy
was as follows (between group differences
were not statistically significant):
- 91.2% of women with AN
- 92.2% of women with BN
- 93.2% of women with EDNOS-P (↑
intake of Fe-containing supplements)
- 90.6% of women with BED
- 93.5% of the women without EDs
Abbreviations: ED: eating disorder; AN: Anorexia Nervosa; BN: Bulimia Nervosa; BED: Binge Eating Disorder; EDNOS-P: Eating Disorder Not Otherwise Specified – Purging subtype;
MoBa: Norwegian Mother and Child Cohort Study; TSH: Thyroid-Stimulating Hormone; T4: Free Thyroxine (T4); IGF-I: Insulin-Like Growth Factor I; IGFBP1: IGF Binding Protein 1;
Hb: Hemoglobin; Fe: Iron; DSM: Diagnostic and Statistical Manual of Mental Disorders; ICD-10: International Statistical Classification of Diseases and Related Health Problems; GW:
gestational week; ↑: higher; ↓: lower.
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Table 3. Studies investigating eating behavior in pregnant women with eating disorders.
Source Study Design Country Sample ED Diagnosis n Prevalence of EDs Outcome Main Findings
Crow et al., 2008
[23]
Cross-sectional
analysis of the
McKnight
Longitudinal Study
of Eating Disorders
United States of
America
Pregnant
women with
full/subthreshold
AN, BN or BED
EDE 42
AN (n = 5; 11.9%); BN (n
= 15; 35.7%); BED (n = 4;
9.5%); partial AN (n = 5;
11.9%); partial BN (n = 10;
23.8%); partial BED (n =
3; 7.1%)
Eating behaviors and disordered
eating cognitions over the course
of pregnancy
Frequency of objective binge eating episodes
per 28 days intrapartum: 2.9 (vs. 8.7
prepartum)
Micali et al.,
2007
[34]
Cross-sectional
analysis of the
ALSPAC study
United
Kingdom
Pregnant
women with
and without
recent/past AN,
BN, AN + BN
Self-reported
questionnaire at
12 weeks of
gestation
12,252
0.5% recent ED (n = 57; 6
AN, 51 BN); 3.2% past ED
(n = 395; 167 AN, 158 BN,
70 AN + BN)
18 GW: Self-induced vomiting,
laxative use, exercise behavior,
shape and weight concern; 32 GW:
appraisals about weight gain
during pregnancy, dieting, LOC
Dieting in pregnancy:
- recent ED: 11.3%
- past ED: 4.4%
- nonobese controls: 2.5%
LOC:
- recent ED: 72.5%
- past ED: 42.8%
- nonobese controls: 36.1%
Women with recent BN were more likely to
report LOC in pregnancy compared to all
other groups
Crow et al., 2004
[35]
Cross-sectional
analysis of a
longitudinal study
(follow-up period:
10 – 15 years)
United States of
America
Pregnant
women with BN
EDI; SCID;
Eating
Disorders
Questionnaire;
self-report of
BN symptoms
129 all BN Bulimic symptoms, alcohol, drug,and tobacco use during pregnancy
Frequency of binge eating during pregnancy
was rated as:
- decreased by 59.6%
- increased by 7.4%
- unchanged by 33.0%
The prevalence of alcohol use decreased after
pregnancy was recognized (35% vs. 14%)
Blais et al., 2000
[20] Longitudinal Study
United States of
America
Pregnant
women with
AN and BN
LIFE-EAT II
every 6 month 82
31,7% AN (AN-R: n = 7;
AN-BP: n = 19); 68.3% BN
(n = 56)
Pregnancy outcome (live birth,
therapeutic/spontaneous abortion),
ED symptomatology (restrictive
eating, binging, etc.)
BN subjects:
↓ frequency of binging from prepregnancy to
post-pregnancy
AN subjects:
No significant differences were seen for
binging frequency and restrictive eating
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Table 3. Cont.
Source Study Design Country Sample ED Diagnosis n Prevalence of EDs Outcome Main Findings
Morgan et al.,
1999
[37]
Retrospective
analysis
United
Kingdom
Pregnant
women actively
suffering from
BN
EDE, SCID 94 all BN
Symptoms of bulimia nervosa and
associated psychopathology at
conception, each trimester and
postnatally
Objective binge episodes improved with each
passing trimester of pregnancy
Lemberg et al.,
1989
[38]
Longitudinal study United States ofAmerica
Pregnant
women with an
active AN, BN
or mixed
symptoms
Retrospective,
55-item
questionnaire
on ED
symptoms and
course of
pregnancy
43
57% AN-R;
77% BN; 16%
combination of both
Eating behaviors both antenatal
and postnatal
Women who restricted their intake (n = 36):
- 65% reported improved nutrition or
stopping restricting // complete
cessation: 7%
Women who binged (n = 41):
- improvement: 56% // worsening: 18.6%
// complete cessation: 14%
All women: 12% ↑ impulsivity with food by
overeating
Lacey et al., 1987
[36] Longitudinal study
United
Kingdom
Pregnant
untreated BN
women
St George’s
Hospital eating
disorder unit;
DSM-III
20 all BN Impact of pregnancy on dietarydifficulties of the bulimic woman
19 of the 20 subjects reduced frequency of
binge eating over the course of pregnancy;
only 5 patients were binge eating during the
3rd trimester; 75% having a complete
cessation of binging by the 3rd trimester
Abbreviations: ED: eating disorder; AN: Anorexia Nervosa; AN-R: Anorexia Nervosa Restrictive subtype; AN-BP: Anorexia Nervosa Binge-Purge subtype; BN: Bulimia Nervosa; BED:
Binge Eating Disorder; LOC: Loss of control over eating; ALSPAC: Avon Longitudinal Study of Parents and Children; EDE: Eating Disorder Examination; Eating Disorder Inventory;
Structured Clinical Interview for DSM Axis I Disorders (SCID); LIFE-EAT II: Eating Disorders Longitudinal Interval Follow-up Evaluation; DSM: Diagnostic and Statistical Manual of
Mental Disorders; GW: gestational week; ↑: higher; ↓: lower.
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4. Discussion
This systematic review analyzed diet quality, nutritional biomarkers and dietary supplement use
as well as dysfunctional eating behaviors in women with a current or past ED during pregnancy. Given
the fact that, up to now, only three studies have investigated dietary intake and diet quality in women
with EDs during pregnancy [29–31], and only one study has investigated nutritional biomarkers [32]
and dietary supplement use [33] in pregnant women with EDs, a clear finding of our review is that
more research in this area is urgently needed.
4.1. Dietary Intake and Patterns in Pregnant Women with Eating Disorders
Summarizing the current findings of the three relevant studies, there is congruent evidence for an
adequate diet in pregnant women with EDs, although there are specific subgroup differences [29–31].
The strengths of these studies are their population-based, longitudinal design, and therefore very
large sample sizes. However, all cited studies have a general limitation regarding the examination
of food intake with the use of food frequency questionnaires, as they rely on memory and reported
intakes, which are subject to measurement errors [39]. Moreover, the items of the FFQ are adapted
on the specific diet of a country; thus, carefulness is required regarding participants with different
ethnic backgrounds [31]. Another weakness is the use of standard portion sizes to assess nutrient
intakes from the FFQs, resulting in imprecise estimates of the actual food quantity [29,30]. It remains
unclear whether the FFQ is a valid tool for the dietary assessment in pregnant women with EDs who
experience worries and feelings of guilt or embarrassment for not caring for their unborn children, as
they may under- or over-report specific food items (e.g., energy-dense foods) [31]. However, several
studies conclude that the FFQ is a valid tool for ranking women in accordance with their nutrient
intakes during pregnancy [40–42].
Nguyen et al. calculated a higher diet quality score for women with a history of EDs, not
differentiating the disorder into active, past or type of ED [31]. Furthermore, the exact dietary data was
not presented in the article. Micali et al. examined nutrient and food group intakes of pregnant women
with lifetime AN, BN and both [29]; Siega-Riz et al. investigated those of women with active BN and
active BED [30]. Consequently, except for the BN group, the other subgroups cannot be compared
on the basis of uniform diagnoses between those studies. Nevertheless, the data on dietary intake
in pregnant women with a history of AN, BN and AN + BN suggests a relatively good diet quality,
supported by a vegetarian dietary pattern with lower intakes of meat and similar protein, fat and
carbohydrate intakes compared to controls. However, these results can also be the result of persistent
ED symptoms during pregnancy [31]. More precisely, women whose ED cognitions are present in
pregnancy might have made more informed choices about a ‘healthy’ diet that included low caloric
foods (e.g., vegetables, skimmed milk) to prevent further weight gain [31] or to avoid ‘fattening’ foods
during an interval when purging episodes may be reduced [30]. If so, those women would have scored
higher on the diet quality. An alternative explanation for better nutrition in women with a history of
AN, BN or both is an improvement in the ED symptoms during pregnancy, which is suggested by the
majority of previous studies in this field [20–23]. This is supported by the notion that, especially during
pregnancy, expectant mothers are often highly motivated to optimize their lifestyle [1]. However,
women with BED before and during pregnancy showed higher energy and overall fat intakes and
lower intakes of some nutrients compared to controls. For women with BED, pregnancy could be a
trigger for the continuation or even deterioration of symptoms [22].
The higher consumption of artificially sweetened beverages among women with active and past
BN and BED [24] might be a reflection of their ED pattern in reducing added sugars. Summarized data
from three very large prospective cohort studies showed several risks which were associated with the
consumption of artificially sweetened beverages by pregnant women, including prematurity and the
diagnosis of asthma in their children up to the age of seven years [43].
Similarly, the high consumption of caffeine (>355 mg/day), especially in women with AN and
AN + BN, is of high concern, since caffeine and coffee consumption during pregnancy might be
Nutrients 2019, 11, 840 12 of 17
associated with spontaneous abortion at daily levels of 300 mg caffeine and above in a dose-dependent
way (7–19% for every increase in caffeine intake of 100–150 mg/day) [44,45]. Based on limited data,
a Cochrane meta-analysis was unable to conclude on the effectiveness of the abstention from caffeine
on birth weight or other relevant endpoints [46]. In a clinical sample of ED patients, the main reasons
for consuming caffeinated beverages were appetite suppression, feeling of fullness, facilitation with
purging, and increasing the metabolic rate to enhance energy expenditure [47]. There is evidence that
habitual coffee consumption plays a possible role in weight loss (increased metabolic rate, energy
expenditure, lipid oxidation, and lipolytic and thermogenic activities) [48]. However, the American
College of Obstetricians (ACOG) and the European Food Safety Authority (EFSA) recommend that
pregnant women should drink no more than 200 mg of caffeine per day [49,50].
Lastly, the average intake of all nutrients was sufficient for women with active and past EDs,
except for potassium and phosphorus being very high and iron and folate being much lower than
recommended in the analyses by Siega-Riz et al. [30]. However, nutrient intakes from supplement use
were not included in the analyses.
4.2. Maternal Biomarkers of Nutrition and Dietary Supplement Use in Pregnant Women with Eating Disorders
Both studies that identified nutritional biomarkers during pregnancy showed an increased risk of
maternal iron deficiency anemia (IDA) for women with AN during early pregnancy [15,32]. However,
data of the nutritional biomarkers throughout pregnancy was not available, since the determination was
performed only in one blood sample in early pregnancy [32]. The etiology of anemia is multifactorial
and includes insufficient dietary intake of folate, vitamin B12 and A, along with iron, which is the most
common nutritional cause [51]. According to previous World Health Organization (WHO) reports,
on average, about 50% of all cases of anemia in pregnancy were due to iron deficiency [52]. During
pregnancy, there is an increased need for iron, because more iron is required for the fetus, placenta and
20% increased erythrocytes in the expectant mother [1]. Iron deficiency in pregnancy increases the
risk of premature birth, low birth weight and irreversible or partially reversible neurobehavioral and
cognitive impairments [32,51,53–55]. For instance, Koubaa et al. found that maternal serum levels
of ferritin in women with a history of AN correlated strongly with impaired memory function in
their children at five years of age [32]. Linna et al. did not relate maternal iron status with newborn
outcomes, but they reported that maternal AN was associated with several adverse perinatal outcomes
(e.g., slow fetal growth, very premature birth, small for gestational age, low birth weight), which could
be mediated by low folate or iron intakes during pregnancy [15]. If an IDA is medically diagnosed,
iron supplementation in addition to sufficient intake of iron-rich foods is recommended [1]. Therefore,
pregnant women with a history of EDs, and particularly of AN, should be closely monitored in terms
of nutrient deficiencies.
To our knowledge, the study by Dellava et al. is the only study to date that examined the dietary
supplement intake in pregnant women with EDs compared to control women [26]. Unfortunately, it
was not possible to determine if women with EDs consumed more or less micronutrients from dietary
supplements than women without EDs, since information of the amount of each item contained in
the dietary supplements was not collected [26]. It would also be important to know whether women
with EDs were instructed by their gynecologist to take dietary supplements [26]. Over 90% of women
with EDs used dietary supplements during pregnancy, with folic acid being the most commonly
used supplement. Folic acid supplement use was higher during pregnancy than periconceptional
for all women [26]. Numerous epidemiological studies and subsequent meta-analyses have shown
that a periconceptional folic acid supplementation of 400 µg (alone or in combination with other
micronutrients) can reduce the risk of childhood malformations of the nervous system (neural tube
defects) [56,57]. However, in the study by Dellava et al., the increase in folic acid supplementation
prior to pregnancy in women with and without EDs was likely too late to prevent birth defects
associated with folate deficiency according to the Norwegian recommendations [26]. Therefore,
involved specialists should motivate women with EDs to supplement critical nutrients (e.g., folate,
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iron, iodine). Supplements could easily be accepted by these women, as they are not associated with
caloric intake [26]. However, in women with purging behavior, it is questionable as to how many
supplemented nutrients might be absorbed at the intestinal absorption site.
4.3. Dysfunctional Eating Behavior in Pregnant Women with EDs
In terms of behavioral aspects of eating, pregnancy is associated with an overall improvement
in the severity of dysfunctional eating behavior for most women [20,23,34–38]. Reasons for the
improvement in eating behavior may include the relief of a sense of responsibility for body weight
and shape and the woman’s worries about its harming effects on her unborn child [37]. However,
pregnancy might also be a trigger for the deterioration of bingeing and overeating [22,38]. After all,
every tenth pregnant woman with a recent ED reports restrictive intake, which is worrisome [34].
Reasons for the intensification of dysfunctional eating behaviors may include increased anxiety over
weight gain [38]. Furthermore, physiological changes in the course of pregnancy, such as changes in
satiety associated with an altered leptin level, may have important influences on eating behavior [58].
The increased rates of LOC, both in women with and without EDs, might be correlated with general
ravenous appetite experienced in pregnancy. Interestingly, in the study by Blais et al., pregnancy
outcomes (lower live birth rates, higher therapeutic abortion rates) of women with AN and BN were
not associated with the maternal age, or the presence of ED symptoms at conception [20].
Additionally, in the postpartum phase, the improvement seems to decline, and dysfunctional
eating behaviors tend to return toward prepregnancy levels [29]. Therefore, pregnant women with
eating disorders need enhanced intrapartum and postnatal support. From a nutritional point of view,
the latter is of great importance regarding (breast)feeding practices in women with EDs. For example,
in a study with 20 bulimic women, three mothers reported that they restricted the dietary intake of
their children within the first year of life [36].
4.4. Strengths and Limitations
This is the first systematic review that has examined pregnancy nutrition and related issues in
women with a history of EDs. The strengths of this review are its methodical procedure according
to the PRISMA statement and the focus on nutritional aspects of eating disorders during pregnancy.
Thus, this review draws attention to important gaps in the eating disorder research.
Given the fact that the studies eligible for this review were very heterogeneous, a quality rating
and meta-analysis could not be performed. The articles were ranging over a time span of 30 years;
consequently, consistent diagnostic criteria for EDs were not applied. Another major issue is the
inadequate diagnostic identification of EDs through self-report in some of the reviewed studies.
Therefore, a reporter bias and misclassification of EDs cannot be ruled out. Furthermore, women
who reported an ED might have a milder form of ED, since women who suffer from a severe ED
might not participate in research studies or might not report their ED accordingly due to potential
feelings of sorrow and guilt. Consequently, the prevalence of women with ED and differences in
dietary intake might be underestimated. Moreover, it was not possible to ascertain between active
and lifetime ED during pregnancy in some studies, resulting in mixed study samples of reduced
comparability. There is a limited generalizability in studies that extracted data from the MoBa study,
since differences exist between the study sample and the general population in terms of educational
level and multivitamin consumption. From the seven studies investigating dysfunctional eating
behavior of pregnant women with EDs, three studies had small sample sizes [23,36,38], two studies
relied on retrospective recall [35,37] and, unfortunately, only one study included a control group of
women without EDs [34].
5. Conclusions and Future Directions
Based on our four research questions investigated in the present systematic review, our main
findings are as follows: (1) considering the drawback that dietary intakes were assessed by self-report,
Nutrients 2019, 11, 840 14 of 17
pregnant women with a history of EDs show a similar dietary intake to healthy pregnant women;
there is evidence that women with EDs have a sufficient diet quality and are more likely to follow a
vegetarian dietary pattern. Women with BED seem to be an exception as they show inadequate energy
and fat intakes; (2) the startling caffeine and coffee consumption, especially in pregnant women with
AN and AN + BN, and the use of artificially sweetened beverages in pregnant women with active
and past BN and BED is of high concern and needs further investigation in relation to fetal outcomes;
(3) women with AN were at increased risk of experiencing iron deficiency anemia in pregnancy;
anyhow, women with EDs did not differ in overall dietary supplement use compared to healthy
women; (4) dysfunctional eating behaviors (bingeing, dieting) improved substantially with pregnancy.
We feel that the issue of EDs in pregnancy is still an understudied field. There is still no consistent
answer to the underlying biological mechanisms that might explain the increased risk for adverse
perinatal outcomes in women with EDs. As outlined above, most of the current evidence in the
field is derived from self-report data, which is prone to biases, e.g., due to influences of social
desirability or memory gaps. This highlights the need for method combinations, integrating data
from self-report, observational data, and in order to elucidate consequences of nutrition practices
for fetal development, ideally also from neuropsychological and neurobiological methods [32,59].
For example, fetal magnetoencephalography (fMEG) is a non-invasive method to study fetal brain
activity, which has previously revealed evidence that the maternal metabolism might program the
fetal brain [60,61]. However, the first step is the adequate assessment and identification of EDs
through medical professionals (general practitioner, gynecologist, or fertility specialist), ideally before
pregnancy [62]. Paslakis and de Zwaan [62] recently provided clinical recommendations and specific
algorithms for the management of pregnant females with EDs and for females with EDs seeking
fertility treatment, underlining the importance of an interdisciplinary approach.
Regarding the research gaps concerning pregnant women with EDs, nutrition quality/food
intake (including the adherence to a vegan diet), gestational weight gain, gestational diabetes, and
dysfunctional behaviors (including substance misuse) are just a few topics which urgently require
further investigation. Especially during pregnancy, women with EDs might be highly motivated to
change their behavior in favor of their developing child. Therefore, studies on the treatment of EDs
during pregnancy are urgently needed to ensure an optimal development of the fetus and to contribute
to the prevention of intergenerational transmission of EDs.
Based on the evidence available, the assessment of maternal nutritional status is complex, but
especially needed for vulnerable groups like women with EDs during pregnancy. With the exception
of women with BED, food intake seems sufficient during pregnancy and dysfunctional eating habits
are improved, which is an encouraging finding. Particularly women with active EDs might need
nutritional counselling and close monitoring of nutrient deficits. More research is needed to confirm
previous studies and to identify treatment interventions that support lasting improvements in eating
behaviors and dietary intake in the postpartum phase.
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